Heterogeneity of Checkpoint Inhibitor–Associated Pneumonitis: A Multicenter Study on Inflammatory Subtypes and Clinical Outcomes
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Medicine"
DOI: 10.1002/cam4.71041
Abstract: Checkpoint inhibitor–associated pneumonitis (CIP) is a serious manifestation following tumor immunotherapy, typically mediated by T lymphocytes. However, the heterogeneity in blood inflammatory profiles and its implications on clinical characteristics and outcomes for CIP remain underexplored. read more here.
Keywords: inhibitor associated; checkpoint inhibitor; associated pneumonitis;
Waterproofing spray-associated pneumonitis review
Sign Up to like & getrecommendations! Published in 2021 at "Medicine"
DOI: 10.1097/md.0000000000025054
Abstract: Supplemental Digital Content is available in the text Abstract Waterproofing spray-associated pneumonitis (WAP) proceeds to acute respiratory failure and is characterized by diffuse bilateral ground-glass opacities on computed tomography; however, the detailed characteristics of WAP… read more here.
Keywords: pneumonitis; associated pneumonitis; patients wap; wap aep ... See more keywords
Immune Checkpoint Inhibitor-associated Pneumonitis: A Narrative Review
Sign Up to like & getrecommendations! Published in 2025 at "Western Journal of Emergency Medicine"
DOI: 10.5811/westjem.20305
Abstract: Immune checkpoint inhibitors (ICI), such as pembrolizumab, nivolumab, durvalumab and ipilimumab, have significantly enhanced survival rates for multiple cancer types such as non-small cell lung cancer, melanoma, Hodgkin lymphoma, and breast cancer, and they have… read more here.
Keywords: cancer; immune checkpoint; pneumonitis; ici associated ... See more keywords